Current issue
3 . 2014
Hepatitis A and E
Content
Editorial

Editorial

Abstract
Congratulations

The 90 th anniversary of the Department of Infectious Diseases, Kazan State Medical University (scientific heritage)

Abstract
News

News

Abstract
International practice

Viral hepatitis E. Current concepts in the etiology, epidemiology, diagnosis, clinical findings and prevention

Abstract
Hepatitis E is a viral hepatitis caused by infection. It is spread by faecal-oral transmission. Hepatitis E virus (HEV) is responsible for epidemics and endemics of acute hepatitis in humans, mainly through waterborne, foodborne, and zoonotic transmission routes. This

Acute viral hepatitis – Should the current screening strategy be modified?

Abstract
Background. The epidemiology of viral hepatitis has changed. Since the introduction of safe and effectivevaccines for hepatitis A and B in 1980s, the incidence of acute infections caused by these viruses has beendeclining in the UK. At the same time, hepatitis E virus (HEV)

Hepatitis E in liver biopsies from patients with acute hepatitis of clinically unexplained origin

Abstract
Hepatitis E virus (HEV) is a small RNA virus and the infectious agent of hepatitis E that occurs worldwide either as epidemics in Asia caused by genotype 1 and 2 or as sporadic disease in industrialized countries induced by genotype 3 and 4. The frequency might be

Viral hepatitis A: past, present and future

Abstract
Relevance of hepatitis A is caused by several factors: worldwide prevalence of the infection (includin g Russia); economic and social Importance; high frequency of disease in children and adults; eruptions ; chronic and severe disease possibility; different clinical forms;

Hepatitis A virus: host interactions, molecular epidemiology and evolution

Abstract
Infection with hepatitis A virus (HAV) is the commonest viral cause of liver disease и presents an important public health problem worldwide. Several unique HAV properties и molecular mechanisms of its interaction with host were recently discovered и should
Practitioner’s consult

The resolution of Experts Council Meeting dedicated to new possibilities of genotype 1 chronic hepatitis C virus infection treatment in Russian Federation

Abstract

Modern pathogenetic therapy of chronic hepatitis C

Abstract
Clinical laboratory studies were made in 87 patients with chronic hepatitis С (CHC). Hie comprehensive studies involved the evaluation of a number of oxidative metabolic parameters, antioxidant enzymes, and nitric oxide metabolism products. All the studies were

Problems of pulmonary cryptococcosis diagnostics. The clinical case

Abstract
The authors considered modern basic cryptococcosis concepts and briefly analyzed the current state about diagnosis and treatment, with particular attention paid to the pulmonary form of this disease. The authors make presentation the case of late diagnosis of pulmonary
Announcements

Announcements

Abstract

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»